Literature DB >> 9426201

"Invasive-growth" signaling by the Met/HGF receptor: the hereditary renal carcinoma connection.

A Bardelli1, L Pugliese, P M Comoglio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9426201     DOI： 10.1016/s0304-419x(97)00026-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN： 0006-3002


× No keyword cloud information.
  8 in total

1.  CD44 is required for two consecutive steps in HGF/c-Met signaling.

Authors:  Véronique Orian-Rousseau; Linfeng Chen; Jonathan P Sleeman; Peter Herrlich; Helmut Ponta
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

2.  Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin.

Authors:  Véronique Orian-Rousseau; Helen Morrison; Alexandra Matzke; Thor Kastilan; Giuseppina Pace; Peter Herrlich; Helmut Ponta
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

3.  Direct interaction of focal adhesion kinase (FAK) with Met is required for FAK to promote hepatocyte growth factor-induced cell invasion.

Authors:  Shu-Yi Chen; Hong-Chen Chen
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

4.  Activation of cdc42, rac, PAK, and rho-kinase in response to hepatocyte growth factor differentially regulates epithelial cell colony spreading and dissociation.

Authors:  I Royal; N Lamarche-Vane; L Lamorte; K Kaibuchi; M Park
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

5.  Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth.

Authors:  A Bardelli; P Longati; D Gramaglia; C Basilico; L Tamagnone; S Giordano; D Ballinari; P Michieli; P M Comoglio
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

6.  Protein tyrosine phosphatase PTP-S binds to the juxtamembrane region of the hepatocyte growth factor receptor Met.

Authors:  E Villa-Moruzzi; F Puntoni; A Bardelli; E Vigna; S De Rosa; P M Comoglio
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

7.  The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma.

Authors:  Kate Lynn J Bill; Jeannine Garnett; Xiaoyan Ma; Caitlin D May; Svetlana Bolshakov; Alexander J Lazar; Dina C Lev; Raphael E Pollock
Journal:  Lab Invest       Date:  2015-06-01       Impact factor: 5.662

Review 8.  Hepatocyte Growth Factor Isoforms in Tissue Repair, Cancer, and Fibrotic Remodeling.

Authors:  Ognoon Mungunsukh; Elizabeth A McCart; Regina M Day
Journal:  Biomedicines       Date:  2014-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.